A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Completed · Phase 3 · Has a placebo group

Conditions studied: Diabetes

In brief

The purpose of this trial is to understand if adding saxagliptin to metformin therapy is safe and works better than taking either saxagliptin or metformin alone

Key facts

Study ID
NCT00327015
Run by
AstraZeneca
People needed
1306
Starts
2006-05-01
Expected to finish
2008-12-01
Last updated by the study team
2015-04-29

Who can join

Age: 18 and older, up to 77. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.